IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.353
AS - Asia 1.906
NA - Nord America 1.902
SA - Sud America 275
AF - Africa 149
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.811
SG - Singapore 856
IE - Irlanda 619
IT - Italia 466
HK - Hong Kong 340
DE - Germania 312
CN - Cina 261
SE - Svezia 245
BR - Brasile 221
RU - Federazione Russa 203
VN - Vietnam 136
BJ - Benin 115
KR - Corea 93
UA - Ucraina 92
GB - Regno Unito 79
FR - Francia 66
IN - India 59
CA - Canada 55
FI - Finlandia 52
PL - Polonia 36
AT - Austria 33
JP - Giappone 33
MX - Messico 28
NL - Olanda 28
TR - Turchia 28
AR - Argentina 23
BD - Bangladesh 22
EE - Estonia 21
ID - Indonesia 21
IR - Iran 21
CZ - Repubblica Ceca 19
ES - Italia 18
ZA - Sudafrica 16
DK - Danimarca 13
LT - Lituania 13
RO - Romania 11
BE - Belgio 10
EC - Ecuador 10
AE - Emirati Arabi Uniti 7
CL - Cile 6
JO - Giordania 6
MA - Marocco 6
CH - Svizzera 4
DO - Repubblica Dominicana 4
GR - Grecia 4
IQ - Iraq 4
PE - Perù 4
VE - Venezuela 4
AU - Australia 3
KE - Kenya 3
PY - Paraguay 3
CO - Colombia 2
CY - Cipro 2
DZ - Algeria 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BO - Bolivia 1
CM - Camerun 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.590
Salva come PNG Salva come JPEG
Città #
Dublin 615
Hong Kong 338
Singapore 268
Ashburn 173
Beijing 170
Jacksonville 141
Cotonou 115
Los Angeles 109
Seoul 90
Moscow 69
Munich 69
Chandler 67
Dearborn 58
Novara 55
Ho Chi Minh City 53
Buffalo 49
New York 48
Dallas 45
Mülheim 44
Turin 42
Rome 40
Lawrence 35
Princeton 35
Boardman 34
Milan 33
Wilmington 32
Helsinki 28
Tokyo 26
Stockholm 25
São Paulo 25
Bremen 24
Hanoi 24
Strasbourg 24
Frankfurt am Main 23
Nuremberg 23
Warsaw 23
Houston 20
Santa Clara 20
Toronto 20
Chennai 18
San Mateo 17
Vienna 17
Brooklyn 16
Phoenix 16
Amsterdam 15
Brno 15
Denver 15
London 15
Montreal 15
Orem 15
Seattle 15
Vercelli 15
Ankara 14
Piemonte 14
Poplar 14
Falkenstein 13
Jakarta 13
Johannesburg 13
Mexico City 12
Redondo Beach 12
Turku 12
Zanjan 12
Atlanta 11
Rio de Janeiro 11
The Dalles 11
Boston 10
Brussels 10
Monmouth Junction 10
Chicago 9
Kocmyrzów 9
Tianjin 9
Kocaeli 8
Borgomanero 7
New Delhi 7
Ottawa 7
San Francisco 7
San Jose 7
Amman 6
Ann Arbor 6
Cassano Magnago 6
Guarulhos 6
Mumbai 6
Querétaro 6
Roubaix 6
Ardabil 5
Augusta 5
Belo Horizonte 5
Brescia 5
Dhaka 5
Espoo 5
Genoa 5
Hefei 5
Manchester 5
Milwaukee 5
Porto Alegre 5
Quận Bình Thạnh 5
Radauti 5
Sannomaru 5
Thái Bình 5
Assago 4
Totale 3.719
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 201
Retrospective observational study on the use of acetyl-L-carnitine in ALS 173
Advances in stem cell therapy for amyotrophic lateral sclerosis 148
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 132
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 120
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 107
null 105
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 102
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 101
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 95
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 95
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 94
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 93
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 91
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 90
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 90
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 89
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 86
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 85
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 85
Headache in immigrant patients: similarities and differences with Italian population 84
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 82
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 79
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 77
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 77
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 74
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 74
A pilot trial of RNS60 in amyotrophic lateral sclerosis 73
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 73
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 72
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 72
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 71
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 71
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 69
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 68
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 67
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 67
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 65
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 65
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients 64
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 64
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 63
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 62
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 61
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 60
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 60
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 59
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 58
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 57
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 57
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 57
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 56
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 55
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 54
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 54
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 54
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 53
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 53
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 53
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 51
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 50
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 50
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 48
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 48
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 48
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 48
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 48
What is amyotrophic lateral sclerosis prevalence? 48
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 47
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 47
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 47
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 46
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 46
Cell therapy in ALS: An update on preclinical and clinical studies 45
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 44
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 43
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 43
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 42
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 42
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 42
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 41
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 41
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 40
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 40
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? 40
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 39
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 39
Clinical trials in pediatric ALS: a TRICALS feasibility study 37
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders 37
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 34
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 33
Effects of acetyl L-carnitine on oxidative stress in Amyotrophic Lateral Sclerosis patients: evaluation on plasma markers and on members of the neurovascular unit 33
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 33
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort 33
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center 31
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 31
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 31
Variability in Clinical Phenotype in TARDBP Mutations: Amyotrophic Lateral Sclerosis Case Description and Literature Review 31
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset 30
Exploring the use of educational materials for increasing participation in a stretching program: a quality improvement project in people with motor neuron disease 30
Totale 6.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 14 48 9 32 9 34 8
2021/2022304 20 11 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/20251.855 45 38 125 36 50 196 120 164 339 172 168 402
2025/20262.199 289 206 288 687 662 67 0 0 0 0 0 0
Totale 6.775